Incannex Healthcare Inc. (NASDAQ:IXHL – Get Free Report) traded up 5.5% on Monday . The company traded as high as $2.17 and last traded at $2.11. 30,861 shares were traded during trading, a decline of 72% from the average session volume of 111,707 shares. The stock had previously closed at $2.00.
Incannex Healthcare Stock Down 2.8 %
The stock’s 50-day simple moving average is $2.07 and its 200 day simple moving average is $2.33. The firm has a market cap of $132.67 million, a P/E ratio of -1.50 and a beta of 8.11.
Incannex Healthcare (NASDAQ:IXHL – Get Free Report) last released its quarterly earnings data on Monday, September 30th. The company reported ($0.39) EPS for the quarter. The firm had revenue of $0.01 million during the quarter.
Institutional Trading of Incannex Healthcare
Incannex Healthcare Company Profile
Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
See Also
- Five stocks we like better than Incannex Healthcare
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What is a buyback in stocks? A comprehensive guide for investors
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Airline Stocks – Top Airline Stocks to Buy Now
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Incannex Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Incannex Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.